1 2-Distearoyl-Sn-Glycero-3-Phosphocholine Activat
| 證據等級: L5 | 預測適應症: 0 個 |
目錄
- 1 2-Distearoyl-Sn-Glycero-3-Phosphocholine Activat
- Multi-Ingredient Complex (13 Components): No Original Indication — No Predicted New Indication
Multi-Ingredient Complex (13 Components): No Original Indication — No Predicted New Indication
One-Sentence Summary
This candidate is a 13-component mixture whose ingredients span activated charcoal, classical homeopathic botanicals (Gelsemium sempervirens, Sepia officinalis, Staphisagria), mineral salts, and a phospholipid carrier (DSPC). It is not marketed in any jurisdiction covered by this system, carries no DrugBank ID, and the TxGNN pipeline returned zero predicted indications — meaning no repurposing signal could be generated. This record cannot proceed to standard evaluation.
Quick Overview
| Item | Content |
|---|---|
| Original Indication | None on record |
| Predicted New Indication | None — TxGNN returned no output |
| TxGNN Prediction Score | N/A |
| Evidence Level | L5 (model prediction only) — but no prediction was produced |
| US Market Status | Not marketed |
| Number of NDAs | 0 |
| Recommended Decision | Hold |
Why No Prediction Was Generated
The TxGNN model requires a single active pharmaceutical ingredient (INN) that can be mapped to a DrugBank node within the knowledge graph. This submission provided a 13-ingredient string as a single INN:
1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE; ACTIVATED CHARCOAL; CICHORIUM INTYBUS FLOWER; CINCHONA BARK; DELPHINIUM STAPHISAGRIA SEED; FERROSOFERRIC PHOSPHATE; GELSEMIUM SEMPERVIRENS ROOT; PHOSPHORIC ACID; POTASSIUM PHOSPHATE, UNSPECIFIED FORM; ROSA CANINA FLOWER; SEPIA OFFICINALIS JUICE; SODIUM CHLORIDE; VITIS VINIFERA FLOWERING TOP
Because DrugBank lookup returned no matching entity (drugbank_id: null), the KG and DL prediction pipelines had no graph node to start from. The result is a structurally empty Evidence Pack — no indications, no safety data, no MOA, no clinical trials, no literature.
From the ingredient profile, this appears to be a homeopathic or complementary-medicine multi-component preparation. Several components (Gelsemium sempervirens, Sepia officinalis, Staphisagria, Cinchona bark) are classical homeopathic materia medica with no conventional pharmacological MOA recognized in standard drug databases.
Conclusion and Next Steps
Decision: Hold
Rationale: The pipeline cannot evaluate a multi-ingredient string as a single drug entity; no DrugBank mapping, no TxGNN prediction, and no safety data exist for this submission.
To proceed, the following is needed:
- Decompose the mixture: Submit each of the 13 components individually as separate INN queries. Each ingredient that has a DrugBank ID can then be processed through the TxGNN pipeline independently.
- Clarify the product type: Confirm whether this is a registered homeopathic product, a nutraceutical, or a combination drug — the applicable regulatory and evidence framework differs significantly.
- Obtain product dossier: If a specific branded product exists, locate its package insert to establish the claimed indication, dosage, and safety warnings before attempting any repurposing analysis.
- Prioritize pharmacologically active components: Among the 13, Cinchona bark (source of quinine/quinidine) and DSPC (phospholipid carrier) have conventional pharmacological profiles and would be the most tractable candidates for TxGNN analysis.
Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.